[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precigen Inc (PGEN)

Precigen Inc (PGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Precigen Inc 20374 Seneca Meadows Parkway Germantown MD 20876 USA

www.precigen.com Employees: 160 P: 301-556-9900

Sector:

Medical

Description:

Precigen Inc. is a biopharmaceutical company. It specialise in the development of gene and cell therapies for immuno-oncology, autoimmune disorders and infectious diseases. The company's transformative therapeutic platforms, including UltraCAR-T(TM), AdenoVerse(TM) cytokine therapies, multifunctional therapeutics and off-the-shelf AdenoVerse(TM) immunotherapies, as well as ActoBio Therapeutics, Exemplar Genetics and Triple-Gene from our subsidiaries. Precigen Inc., formerly known as Intrexon Corporation, is based in Germantown, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 1,693,427
Enterprise Value, $K 1,756,367
Shares Outstanding, K 356,511
Float, K 208,915
% Float 58.60%
Short Interest, K 40,255
Short Float 11.29%
Days to Cover 9.56
Short Volume Ratio 0.41
% of Insider Shareholders 41.40%
% of Institutional Shareholders 33.51%

Financials:

Annual Sales, $ 9,680 K
Annual Net Income, $ -250,640 K
Last Quarter Sales, $ 23,250 K
Last Quarter Net Income, $ -7,930 K
EBIT, $ -90,000 K
EBITDA, $ -84,740 K

Growth:

1-Year Return 233.10%
3-Year Return 318.58%
5-Year Return -30.65%
5-Year Revenue Growth -90.62%
5-Year Earnings Growth -160.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 05/13/26
Next Earnings Date 08/11/26
Earnings Per Share ttm -0.25
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year 71.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.162 on 06/09/15
Dividend Payout Ratio 0.00%

PGEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 717.50%
Return-on-Assets % 58.48%
Profit Margin % -2,589.26%
Debt/Equity 4.62
Price/Sales 176.71
Price/Cash Flow N/A
Price/Book 84.57
Book Value/Share 0.06
Interest Coverage -63.76
60-Month Beta 1.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.